Today, WHO, in collaboration with key partners and supporters, launched version 2.0 of the Epidemic Intelligence from Open Sources (EIOS) system, used globally for the early detection of public health...

Baby Josephine and her sister Evelyn both faced spinal muscular atrophy type 1. Traditional treatments failed, but Evelyn's participation in a clinical trial for the gene therapy Zolgensma transformed her life. Despite its $2.1 million cost and risks, early intervention with Zolgensma significantly improved outcomes for children diagnosed with SMA.

Florida Surgeon General Joseph Ladapo, MD, PhD, announced Wednesday that the state will work to “end all vaccine mandates,” including for children.“Every last one of them is wrong an...

Victoria Grey, diagnosed with sickle cell disease (SCD) at three months, defied a seven-year life expectancy, suffering for 34 years. Traditional treatments failed until she participated in a groundbreaking CRISPR trial, successfully reactivating healthy hemoglobin production. Victoria is now pain-free, showcasing the potential of genetic medicine to cure chronic conditions.

For over a century, traditional medicine offered pills and surgery, effectively managing many conditions. However, it often falls short for genetic diseases. The advent of precision therapies, such as CRISPR and AAV gene therapy, marks a revolutionary shift, curing root causes rather than managing symptoms, thus transforming patient outcomes.

YouTube video by MicrobeTV